Liestal, Switzerland

Gordon Bradley

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gordon Bradley: Innovator in Pharmaceutical Technology

Introduction

Gordon Bradley is a notable inventor based in Liestal, Switzerland. He has made significant contributions to the field of pharmaceutical technology, particularly through his innovative use of surface active proteins in drug delivery systems. With a total of two patents to his name, Bradley's work focuses on enhancing the effectiveness of topical pharmaceutical formulations.

Latest Patents

Gordon Bradley's latest patents include two groundbreaking inventions. The first patent, titled "Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin," provides a method for using surface active proteins, specifically class I and class II hydrophobins, in topically applied pharmaceutical products. This invention aims to improve the penetration of active ingredients through nails to treat various diseases and disorders. The second patent, "Surface active proteins as excipients in solid pharmaceutical formulations," relates to the use of hydrophobins as excipients in pharmaceutical technology. This invention outlines methods for modifying the properties of pharmaceutical compositions, enhancing their effectiveness and stability.

Career Highlights

Throughout his career, Gordon Bradley has worked with prominent companies in the biotechnology sector. Notably, he has been associated with BASF SE Corporation and B.R.A.I.N. Biotechnology Research and Information Network AG. His work in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical formulations.

Collaborations

Gordon Bradley has collaborated with several professionals in his field, including Andreas Buthe and Andreas Hafner. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Gordon Bradley's contributions to pharmaceutical technology through his innovative patents demonstrate his commitment to improving drug delivery systems. His work with surface active proteins has the potential to significantly enhance the effectiveness of topical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…